Clearbridge Investments, LLC Astrazeneca PLC Transaction History

Clearbridge Investments, LLC

$127 Billion
Q3 2025

A detailed history of Clearbridge Investments, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Clearbridge Investments, LLC holds 4,712,057 shares of AZN stock, worth $421 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

4,712,057

Previous 4,353,354 8.24%

Holding current value

$421 Million

Previous $304 Million 18.83%

% of portfolio

0.29%

Previous 0.26%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$68.72 - $82.11 $24.7 Million - $29.5 Million	358,703 Added 8.24%	4,712,057 $362 Million
Q2 2025 Aug 12, 2025	BUY	$64.87 - $75.0 $56.1 Million - $64.9 Million	864,772 Added 24.79%	4,353,354 $304 Million
Q1 2025 May 13, 2025	BUY	$65.37 - $77.96 $1.59 Million - $1.9 Million	24,393 Added 0.7%	3,488,582 $256 Million
Q4 2024 Feb 12, 2025	SELL	$63.2 - $79.58 $7.53 Million - $9.48 Million	-119,082 Reduced 3.32%	3,464,189 $227 Million
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $13.8 Million - $15.7 Million	179,523 Added 5.27%	3,583,271 $279 Million

Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $12.4 Million - $15 Million	186,010 Added 5.78%	3,403,748 $265 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $22.9 Million - $26.1 Million	-374,709 Reduced 10.43%	3,217,738 $218 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $121 Million - $135 Million	1,951,591 Added 118.94%	3,592,447 $242 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $61.1 Million - $67.5 Million	941,917 Added 134.76%	1,640,856 $111 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $1.81 Million - $1.96 Million	25,858 Added 3.84%	698,939 $50 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $4.11 Million - $4.66 Million	65,037 Added 10.7%	673,081 $46.7 Million
Q4 2022 Feb 10, 2023	BUY	$54.21 - $70.44 $14,040 - $18,243	259 Added 0.04%	608,044 $41.2 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $32.2 Million - $82.5 Million	607,785 New	607,785 $33.3 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $304,803 - $378,833	-6,295 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $27,211 - $31,411	-577 Reduced 8.4%	6,295 $313,000
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $31,735 - $36,537	-598 Reduced 8.01%	6,872 $377,000
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $56,935 - $73,064	1,321 Added 21.48%	7,470 $395,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $2,720 - $3,695	-72 Reduced 1.16%	6,149 $275,000
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $1,564 - $1,773	-39 Reduced 0.62%	6,221 $277,000
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $9.61 Million - $10.7 Million	-257,885 Reduced 97.63%	6,260 $0
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $168,116 - $203,785	-4,737 Reduced 1.76%	264,145 $10.7 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $203,172 - $228,692	5,512 Added 2.09%	268,882 $10.2 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $1.05 Million - $1.19 Million	-30,075 Reduced 10.25%	263,370 $10.4 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $508,057 - $544,820	-14,705 Reduced 4.77%	293,445 $10.3 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $56,345 - $62,600	-1,709 Reduced 0.55%	308,150 $10.8 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $679,794 - $736,779	-21,184 Reduced 6.4%	309,859 $10.8 Million
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $12.4 Million - $14.6 Million	-429,309 Reduced 56.46%	331,043 $11.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	760,352	760,352 $25.9 Million

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Astrazeneca PLC Transaction History